REVIEW
Published on 27 Aug 2025
USP38: an important regulatory factor in tumor malignant progression
doi 10.3389/fimmu.2025.1612723
- 126 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Precision Oncology in Checkpoint Immunotherapy: Leveraging Predictive Biomarkers for Personalized Treatment
Precision Oncology in Checkpoint Immunotherapy: Leveraging Predictive Biomarkers for Personalized Treatment
11k
Total downloads
49k
Total views and downloads
Articles
ORIGINAL RESEARCH
Accepted on 21 Aug 2025
The germinal center-tertiary lymphoid structure (GC-TLS) after neoadjuvant chemo-immunotherapy for locally advanced lung squamous cell carcinoma can predict the disease progression
doi 10.3389/fimmu.2025.1579840
ORIGINAL RESEARCH
Published on 15 Aug 2025
PNI as a predictive biomarker: a novel nomogram of immunotherapy efficacy in advanced breast cancer
doi 10.3389/fonc.2025.1534545
- 454 views
ORIGINAL RESEARCH
Published on 07 Aug 2025
Evaluation of ctDNA-guided adjuvant therapy de-escalation in head and neck squamous cell carcinoma: a comparative cohort study
doi 10.3389/fimmu.2025.1576042
- 635 views
ORIGINAL RESEARCH
Published on 23 Jul 2025
Autonomic nervous system development-related signature as a novel predictive biomarker for immunotherapy in pan-cancers
doi 10.3389/fimmu.2025.1611890
- 1,146 views
ORIGINAL RESEARCH
Published on 18 Jul 2025
Quality-of-life scale machine learning approach to predict immunotherapy response in patients with advanced non-small cell lung cancer
doi 10.3389/fimmu.2025.1600265
- 1,185 views
ORIGINAL RESEARCH
Published on 09 Jul 2025
Integrating pathomics and deep learning for subtyping uveal melanoma: identifying high-risk immune infiltration profiles
doi 10.3389/fimmu.2025.1585097
- 1,035 views
ORIGINAL RESEARCH
Published on 05 May 2025
To determine the role of TRIT1 in the diagnosis, prognosis and immunoinvasion of liver hepatocellular carcinoma
doi 10.3389/fimmu.2025.1563442
- 1,439 views
SYSTEMATIC REVIEW
Published on 01 May 2025
The neoadjuvant immunotherapy for non-metastatic mismatch repair-deficient colorectal cancer: a systematic review
doi 10.3389/fimmu.2025.1540751
- 2,974 views
ORIGINAL RESEARCH
Published on 08 Apr 2025
The transcription factor TSHZ3 promotes tumor immunosuppression and inhibits metastasis in lung adenocarcinoma
doi 10.3389/fimmu.2025.1519815
- 1,403 views
SYSTEMATIC REVIEW
Published on 26 Mar 2025
The efficacy and safety of PD-1/PD-L1 inhibitors in combination with chemotherapy as a first-line treatment for unresectable, locally advanced, HER2-negative gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials
doi 10.3389/fimmu.2025.1566939
- 6,834 views
- 4 citations
ORIGINAL RESEARCH
Published on 11 Mar 2025
Single-cell and transcriptome analyses revealed CTHRC1 a potential therapeutic target mediating invasion and tumor microenvironment in TNBC: experimental validation
doi 10.3389/fimmu.2025.1534981
- 1,735 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore